Trial Details

COMPLETED
Basic Information
Clinical ID c893
Identifier NCT05867550
Trial Title To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: Rifaximin 550 MG|DRUG: Mebeverine 135 MG|DRUG: Psyllium Husk|DRUG: Amitriptyline Hydrochloride 25 MG
Participant Information
Sponsor Bahria University
City Sindh
Country/Region Pakistan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2023-01-03
Primary Completion Date 2023-03-27
Completion Date 2023-06-10